Looking to learn more about outsourcing medical manufacturing? You’ve reached the right place. Watch our blog for white papers, tips, article links and other information focused on helping medical device manufacturers save time and money without cutting quality. If you’d like to learn more about Forefront Medical’s capabilities, visit our About page or our website: http://www.forefrontmedical.com/.
Forefront Medical Technology’s President Walter Tarca contributed a column to the June 2019 issue of Medical Product Outsourcing on Outsourcing and Trade Policies. Read the full column here.
Regulatory changes can have significant impact on product design and market competitiveness. One upcoming example of this impact is the expansion of the European Union’s (EU) list of Restricted or Hazardous Substances, commonly referred to as RoHS 3. The phthalates added to the list are driving a switch from polyvinyl chloride (PVC) to polyurethane (PU) in medical products including tubing, catheters and bags. As with other RoHS directives, regions outside the EU have followed suit in legislation that restricts these substances. And, economies of scale considerations ultimately drive medical device manufacturers to alternatives which are not restricted in any market. Forefront Medical Technology’s latest whitepaper looks at the implications of this legislation and ways a contract manufacturing partner can assist in the effort to fully evaluate the range of acceptable alternatives, the cost impact of a change, and efficient development and commercialization of products utilizing the chosen alternative materials. Read the full paper here.
Forefront Medical Technology will be exhibiting at MD&M West at the Anaheim Convention Center on Feb. 5-7. Click here and use code SPECIALFOR406 to register for a free pass to the exhibits and a 20% discount on the conference price.